This website will offer limited functionality in this browser. We only support the recent versions of major browsers like Chrome, Firefox, Safari, and Edge.
Tim Wilsdon and Antun Sablek present their new study analyzing the expected impact of the GPL on the biotechnology innovation ecosystem. The webinar will discuss the consequences of this landmark legislation for the future of innovation in healthcare in Europe, EU patients and economies within a global race towards health security and competitiveness.
For more information on this event, click here.
In the final part of the series, CRA’s Dr. Nick Davies presents an overview of current and emerging analytical tools and explores the opportunities for their...
This year’s European World Orphan Drug Congress, attended by CRA’s Bhavesh Patel, Michele Pistollato, Charlotte Poon, Owen Male and Clara Zacharko in...
